Exact Sciences has a multipronged approach to cancer testing. Its flagship product line is Cologuard, the market leader in stool-based screening for colorectal cancer, or CRC. Its second-largest ...

And yet the media company's stock (WBD) was falling 6.5% in afternoon trading Thursday, to reverse an earlier postearnings gain of as much as 3.4%. It has now shed 12.6% since closing at a two-year ...

Corporate buybacks are surging, with both the July and year-to-date totals setting records. But that's no reason for bullish stock investors to celebrate.

The U.S. has concluded trade frameworks with top trading partners including the European Union, Japan and South Korea. But deals with others remain works in progress, and Trump is also targeting ...

President Donald Trump is the first president to fire the chief of a key government agency that produces the crucial U.S. jobs report. To hear President Donald Trump and his allies tell it, the ...

1) In a few years I will have to take required minimum distributions (RMDs) from my traditional IRA (currently my only retirement account). I plan to work until age 80 or so. Will I be able to ...

Maryland Stadium Authority is selling approximately $261.8 million in bonds for capital improvements at the Oriole Park baseball stadium and related facilities in Baltimore.

The bottom line: We maintain our $120 fair value estimate, as our outlook is unchanged. We think Disney has positioned itself ...

Toronto-listed stocks fell thanks to a broad-based decline among most Canadian sectors. Consumer services stocks were the top decliners on Thursday, followed by commercial services and retail. On the ...

As most cash gasoline markets are falling from recent peaks in late July, the Pacific Northwest is doing the opposite as prices rallied. The Northwest gasoline market is running 32.5cts over futures, ...

Once KCS merger synergies take hold, the firm expects leverage to normalize back down to about 2.5 times. Given both rails' solid records of execution and free cash generation, we are comfortable ...

With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...